Status:
RECRUITING
TCM Daoyin for Anxiety/Depression: Psychological Effects and Biological Mechanisms
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Collaborating Sponsors:
Shanghai Mental Health Center
Conditions:
Anxiety Symptom
Depression Symptom
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This 12-week single-arm clinical trial investigates the effects of Traditional Chinese Medicine (TCM) Daoyin exercise on anxiety and depression symptoms in 20 participants, followed by a 12-week obser...
Detailed Description
Anxiety and depression are among the most prevalent mental health conditions and are commonly associated with inflammation, immune dysregulation, and metabolic disturbances. Traditional Chinese Medici...
Eligibility Criteria
Inclusion
- Primary symptoms of anxiety and depression, with a Hamilton Anxiety Rating Scale (HAMA-14) score between 14 and 29 and a Hamilton Depression Rating Scale (HAMD-17) score between 7 and 14.
- No prior use of psychotropic medication, or at least six months since discontinuation.
- Aged 18 to 65 years (male or female).
- Clear consciousness and normal cognitive function, with the ability to communicate effectively, read, express thoughts, and engage in daily activities independently.
- Willing and able to comply with blood and stool sample collection.
- Voluntary participation, with signed informed consent provided before enrollment.
Exclusion
- Diagnosed anxiety disorder or depressive disorder based on ICD-10 criteria.
- Bipolar disorder, psychotic disorders (e.g., schizophrenia), or organic mental disorders (e.g., Alzheimer's disease).
- History of alcohol or substance use disorder within the past year, current psychiatric medication use, or high suicide risk.
- Severe or unstable medical conditions, including immune or endocrine disorders or other serious illnesses.
- Physical or psychological limitations preventing participation in the TCM Daoyin intervention.
- Pregnant or breastfeeding women.
Key Trial Info
Start Date :
April 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06921512
Start Date
April 10 2025
End Date
September 30 2027
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Qigong Research Institute
Shanghai, China, 200030